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Identity 




The GREB1 gene is located on the short arm of 
chromosome 2, at 2q25.1, between the genomic sites 
for E2F transcription factor 6 and neurotensin receptor 
2 (Entrez gene 9687). It is encoded on the plus strand 
covering 108.68 kb from 11674242 to 11782912 
(UCSC). The gene structure consists of 60 
exons/alternative exons and 40 distinct introns. 
Transcription 
The GREB1 gene contains a distal enhancer 20 kb 
upstream of the transcription start site containing 3 
estrogen response elements (EREs), which bind 
estrogen receptor α (ERα) in the presence of estrogen. 
In breast cancer cells, the steroid receptor co-activator 
SRC-3, phosphorylated RNA polymerase II and 
actylated histones are also bound in the presence of 
estrogen. Chromatin loops link the three distal EREs 
and the transcription start site, indicating the distal 
enhancer plays a potent role in GREB1 estrogen 
responsiveness (Deschênes et al., 2007; Sun et al., 
2007). 
Three primary representative complete cDNA clones 
have been isolated from an MCF7 (ER+ breast cancer 
cell line) cDNA library, designated GREB1a, GREB1b 
and GREB1c respectively (Ghosh et al., 2000).  
The longest transcript variant is GREB1a, consisting of 
8482 bp spliced from 33 exons. GREB1b is 2521 bp in 
length and is spliced from 11 exons, whilst GREB1c is 
2432 bp long spliced from 10 exons.  
All three variants differ in their 5' and 3' UTRs and 
contain distinct c-terminus regions.  
In addition, up to 10 additional splice variants have 
been identified amongst clones from breast, uterus, 
prostate and brain (Dias Neto et al., 2000; Nagase et al., 
1998).  
Expression of GREB1 variants have also been detected 
in the ovary, prostate and pancreas (NCBI). 
Protein 
Description 
GREB1 protein has 7 isoforms containing a 
transmembrane domain and/or N-myristoylation 
domain. The three well documented isoforms of 
GREB1 protein, GREB1a, GREB1b and GREB1c 
contain 1949, 457 and 409 amino acids, respectively 
(Table 1).  
They share N-terminus end region and containing 
diverging C-terminus end.  
The divergence between 1a and 1b start from 450 aa. 
GREB1c shares first 386 amino acids with GREB1a 
and differs from 387 to 409 amino acids (Ghosh et al., 
2000). 
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Figure 1. (a) The genomic location of GREB1 on the short arm of chromosome 2. (b) The 3 primary splice variants of GREB1, GREB1a, 
GREB1b and GREB1c. Green boxes represent exons, red lines introns. Numbers below exons indicate exon number. Numbers either 
side of variant indicate genomic location of the start and end of each transcript. 
 
Expression 
GREB1 protein expression is found in both normal and
cancerous tissues. Its regulation is not only correlated 
with the presence of a subset of nuclear receptors such
as ERα (Deschênes et al., 2007; Hnatyszyn et al., 2010; 
Lin et al., 2004; Pellegrini et al., 2012), androgen 
receptor (AR) (Rae et al., 2006) and Liver receptor 
Homolog 1 (LRH-1) (Chand et al., 2012) but also 
depends on their activation.  
In breast cancers, GREB1 protein is detected in 
ERalpha+ but not ERalpha-negative breast tumour 
tissue (Hnatyszyn et al., 2010). 
In addition GREB1, regulated by androgens is 
expressed in proliferating prostatic tissue and prostate 
cancer (Rae et al., 2006). 
Localisation 
GREB1 protein expression is predominantly nuclear 
with some cytoplasmic appearance (Hnatyszyn et al., 
2010). 
Function 
The role of GREB1 is emerging as a hormone-
dependent mediator of tumour cell proliferation.  
It has been reported to elicit estrogen and androgen-
stimulated cell proliferation in breast and prostate 
tumours (Rae et al., 2006; Rae et al., 2005; Antunes et 
al., 2012).  
Whether the three variants have the same cellular 
function is unclear and its precise mechanistic action 
within the cell has still not been demonstrated. 
The exact roles that GREB1 have in normal tissue are 
poorly defined. 
Homology 
GREB1 protein together with his paralogue GREB1-
like located on chromosome 18 belong to the GREB1 
family (Nagase et al., 2000). The GREB1 gene 
sequence is conserved in chimpanzee, dog, cow, 
mouse, chicken and monkey (HomoloGene). 
 














A family of estrogen responsive genes discovered in 
MCF7 cells were designated GREB (genes regulated 
by estrogen in breast cancer) (Ghosh et al., 2000). Of 
these novel genes, GREB-1 was identified to have a 
strong correlation with ERα in breast cancer cells 
(Ghosh et al., 2000; Rae et al., 2005). Interestingly, 
GREB-1 was significantly induced by E2 in MCF-7 
cells and its suppression blocked E2 induced growth 
(Rae et al., 2005). Furthermore, the GREB-1 regulatory 
region was found to possess three crucial estrogen 
response elements (EREs) (Lin et al., 2004). In 
addition, ChIP analysis revealed the binding of ERα, 
the steroid receptor coactivator-3, acetylated histones 
and phosphorylated RNA polymerase II to all three 
EREs in the presence of E2 (Deschênes et al., 2007). 
Subsequently, GREB-1 is now a well characterised 
estrogen responsive gene used to identify ERα activity 
(Cai et al., 2011; Chand et al., 2012; Gupta et al., 2012; 
Liu et al., 2012; Rae et al., 2005; Sun et al., 2007; 
Woodfield et al., 2010). Hnatyszyn, et al developed a 
novel GREB-1 antibody which was used to detect 
GREB-1 protein expression in ERα+ve breast cancer 
cells and tissue (Hnatyszyn et al., 2010). 
This positive correlation of GREB1 expression with 
ERα expression is validated in clinical cohorts (Ghosh 
et al., 2000). Another cohort of ER positive breast 
cancers in postmenopausal women (n=104) has shown 
a strong correlation of GREB-1 gene expression with 
plasma E2 levels (Dunbier et al., 2010). In a cohort of 
breast cancer patients (n=64) compared to healthy 
women (n=79) GREB-1 gene expression correlated 
positively with serum E2 levels (Haakensen et al., 
2011). Furthermore in-vivo studies involving the 
transplantation of human breast tissue into female 
athymic mice (Balb/c nu/nu mice) has also 
demonstrated the induction of GREB-1 in response to 
E2 treatment (Wilson et al., 2006). 
Prostate cancer 
Note 
High levels of GREB1 mRNA ,comparable to levels in 
breast cancer MCF-7 cells, were found in prostatic 
tissues and prostate tumours (Rae et al., 2006). GREB1 
was found to be also expressed in the AR-positive cell 
line LNCaP but absent in the AR-negative cell line PC-
3 (Rae et al., 2006). GREB1 expression was responsive 
to androgens via androgen response elements (ARE) 
located ~3.3 kb upstream of the promoter. Knock-down 
of GREB1 in LNCaP cells led to the suppression of 
hormone-induced growth. Using microarray and qRT-
PCR analysis of 33 prostate cancer patients, GREB1 
was found to be over-expressed 13-fold compared to 
normal (Antunes et al., 2012). GREB1 transcript was 




Following exposure to 2R4F tobacco mainstream 
smoke (MSS), GREB1 expression was elevated in 
normal human bronchial epithelial (NHBE) cells 
(Parsanejad et al., 2008). Using human saliva samples 
from 42 lung cancer patients and 74 healthy control 
subjects, transcriptomes were analyzed by gene 
microarray and revealed that GREB1 was one of five 
biomarkers found to be elevated in lung cancer patients 
(Zhang et al., 2012). 
Ovarian cancer 
Note 
To identify epigenetic changes associated with 
progression-free interval of ovarian cancer, 20 samples 
of advanced ovarian cancer with a predominantly 
serous papillary histological subtype were subjected to 
DNA methylation profiling. GREB1 promoter 
hypomethylation was associated with longer survival 
(Bauerschlag et al., 2011). 
Hypertension 
Note 
A SNP, 45718A>G, was significantly associated with 
hypertension and blood pressure level in men, and this 
SNP was in linkage disequilibrium with a SNP present 
at the 3' splice site of intron 11 (Kamide et al., 2005). 
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